4.7 Article

Improved systemic metabolism and adipocyte biology in miR-150 knockout mice

期刊

METABOLISM-CLINICAL AND EXPERIMENTAL
卷 83, 期 -, 页码 139-148

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2017.12.018

关键词

-

资金

  1. National Institutes of Health [R01 DK038765]
  2. Merit Review program of the Department of Veterans Affairs
  3. UAB Diabetes Research Center [P30 DK079626]

向作者/读者索取更多资源

Introduction: Short non-coding micro-RNAs (miRNAs) are post-transcriptional factors that directly regulate protein expression by degrading or inhibiting target mRNAs; however, the role of miRNAs in obesity and cardiometabolic disease remains unclarified. Based on our earlier study demonstrating that miR-150 influences lipid metabolism, we have studied effects of miR-150 on systemic metabolism and adipocyte biology. Materials and Methods: Metabolic phenotypes including body weight, food intake, body composition, glucose tolerance and insulin sensitivity were assessed in WT and global miR-150 KO male mice fed a high-fat diet. Molecular changes in epididymal adipose tissue were evaluated through qRT-PCR and Western blotting. Results: miR-150 KO mice displayed lower body weight characterized by a reduction in % fat mass while % lean mass was increased. Lower body weight was associated with reduced food consumption and an increase in circulating leptin concentrations, as well as enhanced insulin sensitivity and glucose tolerance compared with WT mice. Absence of miR-150 resulted in increased mTOR expression known to participate in increased leptin production leading to reduction of food intake. Expression of PGC-1 alpha, another target gene of miR-150, was also increased together with upregulation of PPAR alpha and glycerol kinase in adipose tissue as well as other genes participating in triglyceride degradation and lipid oxidation. Conclusion: miR-150 KO mice showed metabolic benefits accompanied by reduced body weight, decreased energy intake, and enhanced lipid metabolism. miR-150 may represent both a biomarker and novel therapeutic target regarding obesity and insulin resistance. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据